Latest Health News

Page 6 of 271
Epiminder has enrolled its 100th patient in the DETECT US epilepsy study ahead of schedule, while maintaining A$65.1 million in cash and no borrowings. The company says those reserves can fund clinical development and commercialisation work well into 2028.
Victor Sage
Victor Sage
30 Oct 2026
Mach7 Technologies has completed a costly FY26 reset, cutting operating expenditure by 16% while revenue fell 17% and the net loss widened to A$8.9 million. The company enters FY27 with a higher recurring-revenue mix, new customer orders and A$19.9 million in cash, but no earnings guidance and plenty to prove.
Victor Sage
Victor Sage
30 Oct 2026
Wide Open Agriculture has completed the major physical steps in exiting its German manufacturing facility and is now testing four prospective Asian production partners. The transition could lower fixed costs, but commercial supply still depends on technical trials, partner selection and a definitive agreement.
Victor Sage
Victor Sage
30 Oct 2026
HITIQ has expanded its military research ambitions and added fresh funding during the September quarter, but the company ended the period with $658,242 in cash and estimated funding for only one quarter. Its US collaboration remains non-binding, leaving financing and commercial execution as the immediate tests.
Victor Sage
Victor Sage
30 Oct 2026
OzAurum Resources has strengthened the technical case for a low-capex heap leach operation at Mulgabbie North, with column testing delivering up to 95% gold recovery. But the project’s next phase is now tied to a capital raise after cash fell to A$542,000, equivalent to just 0.8 quarters of estimated funding.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Vitasora Health has signed a Florida healthcare agreement covering an initially addressable 9,000 Medicare patients while estimated October billable care minutes rose 50%. The ASX-listed company also agreed terms for an A$3 million secured facility, but the funding is not yet drawn and carries approval, interest and dilution conditions.
Ada Torres
Ada Torres
30 Oct 2026
Algorae Pharmaceuticals has moved closer to its first expected NSW Health supply orders while reporting stronger preclinical results from its AOS2 drug-discovery platform. The company ended September with $3.15 million in cash and a further $3 million undrawn facility, but its commercial contract carries no minimum volume commitment.
Victor Sage
Victor Sage
30 Oct 2026
Doctor Care Anywhere’s Q3 revenue rose 16% to £11.3 million as its weight-management business delivered its first full quarter, lifting subscription revenue to 19% of the total. The unaudited update also shows modest consultation growth, higher cash and three new distribution partnerships.
Ada Torres
Ada Torres
30 Oct 2026
ImpediMed lifted quarterly revenue and recurring revenue, but weaker-than-expected BCRL sales and a near-total sales team rebuild have put its path to cash-flow break-even under pressure. The company ended September with $11.6 million in cash and 4.7 quarters of funding at the quarter’s operating burn.
Ada Torres
Ada Torres
30 Oct 2026
Spacetalk’s active Mobile subscriber base rose 20% to 61.4k in the September quarter, but revenue fell 32% to $3.1 million as device sales, App revenue and Schools income declined. The $10 million placement lifted cash to $5.2 million, although the company reported only 1.4 quarters of funding at its current operating cash burn.
Victor Sage
Victor Sage
29 Oct 2026
Vectus Biosystems has secured FDA acceptance of a pre-IND Type B meeting for VB0004, a key regulatory step for its idiopathic pulmonary fibrosis programme. The biotech ended September with $410,000 in cash and reported estimated funding for just 1.33 quarters of operations.
Ada Torres
Ada Torres
29 Oct 2026
HyTerra Limited (ASX: HYT) will not proceed with a second McCoy-1 test for now after the Kansas well produced only about 0.1 Mscf/d of gas, with air-corrected hydrogen of 0.4%. The company is reassessing the Ridge Play while shifting attention to its larger Rift Play and preserving cash.
Maxwell Dee
Maxwell Dee
29 Oct 2026

Browse the archive

Full archive